Article info

PDF

Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE

Authors

  1. Correspondence to Dr Kerry A Casey; caseyk{at}medimmune.com
View Full Text

Citation

Casey KA, Guo X, Smith MA, et al
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE

Publication history

  • Received June 19, 2018
  • Revision received September 14, 2018
  • Accepted September 28, 2018
  • First published November 22, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.